Bristol Myers Squibb (BMYMP) Non Operating Income (2016 - 2025)
Historic Non Operating Income for Bristol Myers Squibb (BMYMP) over the last 17 years, with Q4 2025 value amounting to $51.0 million.
- Bristol Myers Squibb's Non Operating Income rose 11672.13% to $51.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$674.0 million, marking a year-over-year increase of 2452.41%. This contributed to the annual value of -$674.0 million for FY2025, which is 2452.41% up from last year.
- Latest data reveals that Bristol Myers Squibb reported Non Operating Income of $51.0 million as of Q4 2025, which was up 11672.13% from $108.0 million recorded in Q3 2025.
- In the past 5 years, Bristol Myers Squibb's Non Operating Income ranged from a high of $702.0 million in Q1 2021 and a low of -$649.0 million during Q1 2022
- For the 5-year period, Bristol Myers Squibb's Non Operating Income averaged around -$13.2 million, with its median value being $26.5 million (2021).
- Per our database at Business Quant, Bristol Myers Squibb's Non Operating Income tumbled by 1430000.0% in 2022 and then soared by 16363.64% in 2023.
- Over the past 5 years, Bristol Myers Squibb's Non Operating Income (Quarter) stood at -$393.0 million in 2021, then surged by 155.22% to $217.0 million in 2022, then surged by 70.97% to $371.0 million in 2023, then plummeted by 182.21% to -$305.0 million in 2024, then surged by 116.72% to $51.0 million in 2025.
- Its Non Operating Income was $51.0 million in Q4 2025, compared to $108.0 million in Q3 2025 and -$494.0 million in Q2 2025.